Aplicaciones de la reacción en cadena de la polimerasa (PCR) en oncohematologia. Detección de enfermedad minima residual / Use of polymerase chain reaction (PCR) in oncohematology. Detection of minimal residual disease
Medicina (B.Aires)
;
55(2): 159-166, mar.-abr. 1995.
Artículo
en Español
| LILACS
| ID: lil-320021
RESUMO
The early detection of clonogenic cells able to survive cytotoxic therapy and to initiate a neoplastic process, defined as Minimal Residual Disease (MRD), represents a major objective for the development of new and more sensitive diagnostic methods. The cloning of different chromosomal translocations along with the application of the Polymerase Chain Reaction (PCR) technique has allowed the characterization of various hematological disorders at the molecular level. This approach has led to the development of PCR based assays able to detect a minimum number of malignant cells with very high specificity. In the present paper we discuss the use of PCR and its value as a predictor for relapse in lymphomas, chronic myelogenous leukemia and acute promyelocytic leukemia, characterized by the t(14;18) t(9;22) and t(15;17) translocations, respectively.
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Reacción en Cadena de la Polimerasa
/
Neoplasia Residual
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Español
Revista:
Medicina (B.Aires)
Asunto de la revista:
Medicina
Año:
1995
Tipo del documento:
Artículo
País de afiliación:
Argentina
Institución/País de afiliación:
Unidad de Investigaciones Oncohematológicas-ONCOLAB/AR
Similares
MEDLINE
...
LILACS
LIS